# The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.

> **NCT07391306** · PHASE2,PHASE3 · RECRUITING · sponsor: **JSC NextGen** · enrollment: 180 (estimated)

## Conditions studied

- IC
- Interstitial Cystitis and Bladder Pain Syndrome
- Interstitial Cystitis, Chronic

## Interventions

- **DRUG:** Neovasculgen®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07391306
- **Lead sponsor:** JSC NextGen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-16
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391306, "The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07391306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*